Results 71 to 80 of about 10,710,575 (236)
Maternal pelvic size not predictive of daughter's breast cancer or ovarian cancer in a large Swedish cohort. [PDF]
Recent studies from Finland reported that maternal pelvic size predicted daughters' breast and ovarian cancer, possibly because maternal pelvic size is a marker for in utero hormone exposure.
Goodman, Anna +8 more
core +1 more source
Aims This investigation aims to elucidate the treatment status of advanced HR+/HER2- breast cancer patients in Hunan Province of Central Southern China from November 2021 to December 2022.
Zhe-Yu Hu +14 more
doaj +1 more source
Purpose/Objective: In the last two decades a growing interest in the use of hypofractionated whole-breast radiotherapy (RT) for women with early breast cancer has been observed.
VIDALI, CRISTIANA +2 more
core +1 more source
Quality of Life Differences between Younger and Older Breast Cancer Patients [PDF]
PURPOSE: This study was designed to investigate quality of life (QOL) differences between younger (
Ah Reum Lee +5 more
core +1 more source
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
According to the latest data released by the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO), among women, breast cancer is the most common type of cancer and the leading cause of cancer-related deaths. Since the
The Society of Breast Cancer China Anti-Cancer Association +1 more
doaj +2 more sources
Node-positive breast cancer: Which are the best chemotherapy regimens? [PDF]
Breast cancer-associated mortality has been significantly reduced since the 1990s, mainly because of early diagnosis and systemic therapeutic interventions.
Bauerfeind, Ingo +6 more
core +1 more source
Purpose An earlier multicenter phase III study demonstrated the safety and efficacy of mitoxantrone hydrochloride injection for tracing (MHI) for detecting sentinel lymph nodes (SLNs) in breast cancer patients.
Dechuang Jiao +9 more
doaj +1 more source
Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer [PDF]
PURPOSE: This study aimed to evaluate the survival benefit of different adjuvant chemotherapy regimens in patients with T1-2N0 triple-negative breast cancer.
박세호
core +1 more source
Clinical research generally focuses on results involving a statistical mean with little attention in trial design to patients who respond considerably better or worse than average.
Kristine De La Torre +4 more
doaj +1 more source
This pioneering study aimed to investigate social disparities in breast cancer (BC) and ovarian cancer (OC) incidence rates among women across Iran's provinces from 2003 to ...
Ahmad Kiadaliri, Aliasghar +2 more
core +1 more source

